 Adenosine vasodilator primary pulmonary hypertension BACKGROUND acute administration vasodilator drugs patients primary pulmonary hypertension reversible pulmonary vasoconstriction usefulness drugs available systemic hypotension vasodilator effects pulmonary circulation advantageous patients METHODS RESULTS purine adenosine pulmonary artery patients primary pulmonary hypertension baseline pulmonary vascular resistance PVR effect PVR patients dose-dependent significant reduction mean maximal percent decrease baseline PVR decrease pulmonary artery pressure increase cardiac output Systemic vascular resistance SVR ratio PVR SVR maximal mean percent decrease baseline adenosine preferential vasodilator effect pulmonary circulation manner CONCLUSIONS pharmacokinetic vasodilator properties adenosine specific role investigation primary pulmonary hypertension